Antiproliferative action of isatine-β-thiocarbohydrazone and N- ethylisatine-β-thiocarbohydrazone on human PBMC and on two neoplastic cell lines

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 3, 1999, Pages 317-324

  Juranic Z ^a   Anastasova, F ^b   Juranic I ^c   Stanojkovic T ^a   Radulovic S ^a   Vuletic N ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^b SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

B16; HeLa; Isatine thiocarbohydrazone; MTT; N ethyl isatine thiocarbohydrazone

Indexed keywords

ISATIN BETA THIOCARBOHYDRAZONE; ISATIN DERIVATIVE; N ETHYLISATIN BETA THIOCARBOHYDRAZONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CYTOSTASIS; DOSE RESPONSE; HELA CELL; HUMAN; HUMAN CELL; LEUKOCYTE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032738185     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Anastasova F.B. Synthesis of heterocyclic azomethynes with potential biological activity. Ph. D. Thesis, Faculty of Science, Skopje (FYRM) 1997.
2. Stolle and Bowles P.E. UeberThiocarbohydrazide. Chem. Ber., 41: 1099, 1908.
3. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
4. Ohno M. and Abe T. Rapid colorimetric assays for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6). J. Immunol. Methods, 145: 199-203, 1991.
5. Juranić Z., Stojiljković M.P., Bočarov-Stančić A., Kilibarda V., Milovanović S.R., Juranić I., Bijelogrlić S., Vuletić N. and Radulović S. T-2 toxin affects proliferation of three different neoplastic cell lines. J. Exp. Clin. Cancer Res., 17(1): 33-40, 1998
6. Seung L.P., Seung S.K. and Schreiber H. Antigenic Cancer Cells that Escape Immune Destruction are Stimulated by Host Cells. Cancer Res., 55: 5094-5100, 1995.
7. 24 does not suppress the proliferation of mouse melanoma B16 cells and human cervix carcinoma HeLa cells in vitro. Archive of Oncology, 6(2): 53-56,1998.
8. Black E.P., Condit R.C. Phenotypic characterization of mutants in vaccinia virus gene G2R, a putative transcription elongation factor. J. Virol. 70: 47-54, 1996.
9. Teitz Y., Barko N., Abramoff M., Ronen D. Relationships between structure and antiretroviral activity of thiosemicarbazone derivatives Chemotherapy-Basel 40: 195-200, 1994.